Back

SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?

European Heart Journal

20 March 2020
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY Pharmacology and Pharmacotherapy

Abstract

Abstract

Contributors

Gabriela M Kuster
Gabriela M Kuster

Author

University Hospital Basel Basel , Switzerland

Otmar Pfister
Otmar Pfister

Author

Thilo Burkard
Thilo Burkard

Author

Qian Zhou
Qian Zhou

Author

University Hospital Basel Basel , Switzerland

Raphael Twerenbold
Raphael Twerenbold

Author

Philip Haaf
Philip Haaf

Author

Andreas F Widmer
Andreas F Widmer

Author

Stefan Osswald
Stefan Osswald

Author

University of Basel Basel , Switzerland

You may be interested in
thumbnail
Congress Session
Challenges in hypertension management
thumbnail
Congress Presentation
Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension
thumbnail
Congress Session
Optimal management of chronic coronary syndromes: putting the evidence into practice